AboutContactSponsorship
Cronicle Press Logo

biotech-startup-funding

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

Asalyxa Bio, Inc., a biopharmaceutical startup developing nano-engineered, immune cell-targeted therapeutics, just announced the closing of…

Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

© 2018-2024 Cronicle Press LLC. All Rights Reserved. All text and photos not attributed copyright Cronicle Press. This content may not be copied or distributed except in excerpt with permission.

Code of Conduct

Privacy Policy

Contact